Research paves the way for genetic control of disease-spreading ticks

Research collaboration by the Texas A&M Department of Entomology and the U.S. Department of Agriculture, USDA, creates potential for genetic tools to control disease-spreading ticks.

Kymera’s stock rises after derma investigation expands; Ligand buys Apeiron

Plus, news about AEON Biopharma, Moderna and Mitsubishi Tanabe: Sanofi expands dermatology trials: Kymera Therapeutics said that expanding the Phase … Sign up to read

July 10, 2024

OCD patients may have higher risk of death from both natural and unnatural causes

People with obsessive-compulsive disorder (OCD) may have an increased risk of death from both natural and unnatural causes than those without the disorder, finds a

January 18, 2024

Trial sponsors say CROs need to own their mistakes and take responsibility –

The panel discussion at the 11th Annual Outsourcing in Clinical Trials Nordics, saw representitives from Camurus, Zealand Pharma and Leo Pharma. Credit: Shutterstock / Gorodenkoff

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.